RecruitingPhase 3NCT06612268
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Sponsor: Novo Nordisk A/S
Minneapolis, MN · +49 more sites
3 recruiting sickle cell disease studies with a site in Minneapolis, MN.
All trials in Minneapolis, MN · All Sickle Cell Disease trials
Sponsor: Novo Nordisk A/S
Minneapolis, MN · +49 more sites
Sponsor: Masonic Cancer Center, University of Minnesota
Minneapolis, MN
Sponsor: Beam Therapeutics Inc.
Minneapolis, MN · +16 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.